Karmanos Cancer Institute releases Cancer Clinical Trials iPhone® and iPad® App for Physicians
DETROIT, Aug. 19, 2013 /PRNewswire-USNewswire/ -- The Barbara Ann Karmanos Cancer Institute (KCI) today announced its new app to help physicians and healthcare professionals become aware of cutting-edge cancer clinical trials, often available only at Karmanos. The KCI Trials App is free and available on the App Store(SM) for the iPhone® and iPad®.
"It is important that physicians are familiar with new treatment options available through our Clinical Trials Program at the Karmanos Cancer Institute," said Connie Claybaker, associate center director, Research Administration, Karmanos Cancer Institute.
According to Claybaker, Karmanos' clinical trials portfolio includes some of the most exciting new investigational agents for cancer patients. The scientific advances Karmanos researchers make every day bring safe and ground breaking treatments from the laboratory bench to the patient's bedside, defining the new standards of cancer care.
"The ultimate goal is to make it as easy as possible for referring physicians and other healthcare professionals to find a clinical trial that may benefit their patients," said Karmanos' Anthony Shields, M.D., Ph.D., associate center director, Clinical Sciences. "With this app, a physician could be meeting with the patient and quickly identify a clinical trial that offers a possible new treatment for consideration."
The new app allows users to search for cancer clinical trials by disease site, keyword, protocol number, phase, or principal investigator. The information displayed for each trial includes the title, objective, principal investigator, disease sites, drugs involved, and eligibility criteria. Plus, users have the option to save protocol information to their 'favorites' and email protocol information to a colleague or patient directly from the app.
The KCI Trials app is now available on the App Store(SM) and users may search KCI Trials to download the app. An Android version is expected to be available by early 2014. For more information, please visit www.karmanos.org/KCITrials or call 1-800-526-6266.
About the Barbara Ann Karmanos Cancer Institute
Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute is one of 41 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $260 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, Karmanos is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 physicians and researchers on faculty at the Wayne State University School of Medicine, and supported by thousands of volunteer and financial donors, Karmanos strives to prevent, detect and eradicate all forms of cancer. Its long-term partnership with the WSU School of Medicine enhances the collaboration of critical research and academics related to cancer care. Gerold Bepler, M.D., Ph.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS (1-800-527-6266) or go to www.karmanos.org.
SOURCE Karmanos Cancer Institute